ArticleTranslational lung cancer research2020

PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy.

Wenfeng Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.